AI assistant
Cellectis — Regulatory Filings 2020
Sep 9, 2020
1190_ffr_2020-09-09_941750cb-81fa-4e82-a2e0-cc71d3cbd793.zip
Regulatory Filings
Open in viewerOpens in your device viewer
6-K/A 1 d22212d6ka.htm 6-K/A 6-K/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K/A
(Amendment No. 1 to Report on Form 6-K (Film No. 201078319))
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date of Report: September 9, 2020
Commission File Number: 001-36891
Cellectis S.A.
(Exact Name of registrant as specified in its charter)
8, rue de la Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Explanatory Note
Cellectis S.A. (Cellectis) is amending its report on Form 6-K furnished to the Securities and Exchange Commission on August 5, 2020 (the Original 6-K) solely for the purpose of adding Exhibit 101, which contains Interactive Data File disclosure with respect to the unaudited interim consolidated financial statements included in the Original Form 6-K in accordance with Rule 405 of Regulation S-T. Except as described above, this amendment does not amend any information set forth in the Original 6-K and no changes have been made to the Original 6-K to reflect events occurring subsequent to August 5, 2020.
This report on Form 6-K/A shall be deemed to be incorporated by reference in the registration statements of Cellectis S.A. on Form F-3 (No. 333-238881) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482 and 333-227717), to the extent not superseded by documents or reports subsequently filed.
Exhibits
| Exhibit | Title |
|---|---|
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ André Choulika |
|---|
| André Choulika |
| Chief Executive Officer |
3
EXHIBIT INDEX
| Exhibit | Title |
|---|---|
| 99.1 | Cellectis S.A.s interim report for the six-month period ended June 30, 2020. |
4